Terns Pharmaceuticals, Inc. (TERN) Revenue History
Annual and quarterly revenue from 2018 to 2024
Compound Annual Growth Rate (CAGR)
Loading revenue history...
TERN Revenue Growth
TERN Revenue Analysis (2018–2024)
As of May 7, 2026, Terns Pharmaceuticals, Inc. (TERN) generated trailing twelve-month (TTM) revenue of $0. The most recent quarter (Q3 2025) recorded $0 in revenue.
Looking at the longer-term picture, TERN's historical revenue data shows various trends over time. The company achieved its highest annual revenue of $1.0 million in 2021.
When compared to Healthcare sector peers including MDGL (+256.8% YoY), and HIMS (+59.0% YoY). Compare TERN vs MDGL →
TERN Revenue vs Peers
Revenue metrics vs comparable public companies
| Company | TTM Revenue | YoY Growth | 5Y CAGR | Op. Margin | Compare |
|---|---|---|---|---|---|
| TERNCurrent | $0 | - | - | - | |
 MDGL | $958M | +256.8% | - | -31.3% | |
 HIMS | $2.3B | +59.0% | +73.6% | 5.2% |
TERN Historical Revenue Data (2018–2024)
| Year | Revenue | YoY % | Gross Profit | Gross Margin | Op. Income | Op. Margin |
|---|---|---|---|---|---|---|
| 2024 | $0 | - | $0 | - | $-101,871,000 | - |
| 2023 | $0 | - | $0 | - | $-102,558,000 | - |
| 2022 | $0 | -100.0% | $0 | - | $-62,029,000 | - |
| 2021 | $1.0M | - | $1.0M | 100.0% | $-49,860,000 | -4986.0% |
| 2020 | $0 | - | $0 | - | $-37,025,000 | - |
| 2019 | $0 | - | $-195,000 | - | $-70,197,000 | - |
| 2018 | $0 | - | $-65,000 | - | $-18,455,000 | - |
See TERN's True Return
Price is only half the story. See total return with reinvested dividends.
Launch CalculatorIs TERN Undervalued?
DCF intrinsic value, peer multiples, and analyst estimates — see what the stock is really worth.
View ValuationCompare TERN vs DBVT
Side-by-side business, growth, and profitability comparison vs DBV Technologies S.A..
Start ComparisonTERN — Frequently Asked Questions
Quick answers to the most common questions about buying TERN stock.
Is TERN's revenue growth accelerating or slowing?
TERN TTM revenue: $0.00. YoY growth: N/A. 5-year CAGR: N/A.
What is TERN's long-term revenue growth rate?
Terns Pharmaceuticals, Inc.'s 5-year revenue CAGR of N/A reflects the variable expansion pattern. Current YoY growth of N/A is near this long-term average.
How is TERN's revenue distributed by segment?
TERN reports revenue by product line and geographic region. Annual and quarterly breakdowns from 2018-2024 are available for download. Segment mix reveals concentration and diversification trends.